CliniMACS CD34-selected cells result in prolonged hemopoietic recovery following high-dose therapy. Conference Paper uri icon

authors

  • Prince, HM
  • Wall, D
  • Chapple, P
  • Haylock, DN
  • Seymour, JF
  • Wolf, M
  • Januscewicz, H
  • Richardson, G
  • Rischin, D

publication date

  • November 16, 2000

published in